CAA: DNA-Protein Interactions Regulating Transcription of the Id Protein Gene During Myogenesis
CAA: DNA-Protein Interactions Regulating Transcription of the Id Protein Gene During Myogenesis
批准号:
9306547
负责人:
Sandra Sharp
金额:
$5.0万
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
1993
资助国家:
美国
项目状态:
已结题
起止时间:
1993-09-01 至 1995-08-31
中文摘要
这项研究得到了美国国家科学基金会女性职业发展奖的支持。这项工作解决了当今分子生物学家面临的最引人注目的问题之一的一个方面,即如何调节动物从单个受精卵发育专门器官的分化过程。其中一个过程就是肌肉形成或肌肉发生。在肌肉形成过程中,肌生成细胞开启了许多基因的表达,这些基因的表达是肌肉功能所必需的。肌肉特异性基因的开启伴随着一个基因家族表达的下调,该基因家族编码的蛋白质的功能似乎是抑制分化,即分化蛋白的Id或抑制剂。Id蛋白并不是肌肉细胞所独有的,有一种假说认为,Id抑制了已经进入特定发育途径的细胞的分化,直到胚胎发生时,当最终分化是合适的。在培养中,当成肌细胞或前肌细胞用药物阿霉素处理,然后放置在通常会分化成肌管或肌细胞的培养基中,它们不会分化。相反,细胞产生异常高水平的mRNA和蛋白质,而在分化过程中应该开启的基因仍然处于关闭状态。基因的开启和关闭是通过在其启动子或控制区的特殊调节蛋白和特定DNA序列之间的相互作用。这些实验旨在确定和比较不同水平表达Id的细胞、肌母细胞、肌管和受阿霉素影响的肌肉细胞中Id基因启动子区域特定蛋白质- dna相互作用的位点。“体内足迹”将用于确定调节蛋白的结合位置。将确定启动子区域的核苷酸序列,并将占用的位点与已知的结合各种组织特异性和普遍存在的调节蛋白的位点进行比较。为了使任何生物发育过程成功地发生,必须仔细地加以调节。分子生物学家已经成功地鉴定了许多控制发育的不同调节蛋白。其中一种蛋白质被称为Id,它的功能之一似乎是阻止前肌肉细胞成为肌肉组织,直到发育的正确时间。这项研究的结果将增加我们对发育的复杂性的认识,这样做可能会对一些由于分子控制失败而发生的发育障碍或疾病提供深入的了解。
英文摘要
This research is supported by an NSF Career Advancement Award to Women. The work addresses a single aspect of one of the most compelling questions challenging molecular biologists today, that is, how the differentiation processes by which animals develop specialized organs from a single fertilized egg are regulated. One such process is that of muscle formation or myogenesis. During myogenesis, myogenic cells turn on expression of numerous genes whose projects are specific to and necessary for function of muscle. The turning on of muscle specific genes is accompanied by down-regulation of expression of a family of genes which code for proteins whose function appears to be to inhibit differentiation, the Id or Inhibitor of differentiation proteins. Id proteins are not unique to muscle cells and one hypothesis is that Id inhibits the differentiation of cells already commited to a specific developmental pathway until such time in embryogenesis as terminal differentiation is appropriate. In culture, when myoblasts or pre- muscle cells are treated with the drug doxorubicin, and are then placed in medium in which they would normally differentiate into myotubes or muscle cells, they do not differentiate. Instead, the cells produce abnormally high levels of Id mRNA and protein, and the genes which should be turned on during differentiation remain off. Genes are turned on and off by interactions between specialized regulatory proteins and specific DNA sequences in their promoter or control regions. These experiments are designed to determine and compare the sites of specific protein-DNA interactions in the promoter region of the Id gene in cells which are expressing Id at different levels, myoblasts, myotubes, and muscle cells affected by exposure to doxorubicin. "In vivo footprinting" will be used to determine where the regulatory proteins are bound. The nucleotide sequence of the promoter region will be determined, and the occupied sites will be compared to those already known to bind various tissue specific and ubiquitous regulatory proteins. In order for any biological developmental process to occur successfully, it must be carefully regulated. Molecular biologists have been successful at identifying a number of different regulatory proteins which control development. One such protein is called Id, and one of its functions appears to be to keep pre- muscle cells from becoming muscle tissue until exactly the right time in development. The results of this research will increase our appreciation for the intricacies of development, and in so doing may provide insight into some developmental disorders or diseases which occur when molecular controls fail.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
RUI: MEF2 and Regulation of Transcription of the Skeletal Muscle Actin Gene
-
批准号:9983140
-
项目类别:Continuing Grant
-
资助金额:$24.0万
-
财政年份:2000
-
负责人:Sandra Sharp
-
依托单位:
RUI: DNA-Protein Interactions Regulating Transcription of the Skeletal Muscle Actin Gene
-
批准号:9604289
-
项目类别:Continuing Grant
-
资助金额:$27.0万
-
财政年份:1997
-
负责人:Sandra Sharp
-
依托单位:
RUI: DNA - Protein Interactions Regulating Transcription of the Skeletal Muscle Actin Gene in Different Myogenic Milieu
-
批准号:9305351
-
项目类别:Continuing Grant
-
资助金额:$28.32万
-
财政年份:1993
-
负责人:Sandra Sharp
-
依托单位:
Gene Manipulation: A Practical Undergraduate Education in the Theory, Methods, and Potential of Biotechnology.
-
批准号:8750387
-
项目类别:Standard Grant
-
资助金额:$0.0万
-
财政年份:1987
-
负责人:Sandra Sharp
-
依托单位:
国内基金
海外基金
登录
查看更多内容
PCV2茎环结构DNA激活cGAS-STING通路诱导的天然免疫应答的作用研究
-
批准号:2026JJ50413
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:王东亮
-
依托单位:
机械力响应型DNA探针用于肿瘤微环境细胞力学可视化与药物筛选研究
-
批准号:2026JJ60135
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:杨思慧
-
依托单位:
自供能传感阵列同步量化游离DNA与PSA实现前列腺癌的诊断和预后判断
-
批准号:JCZRLH202601177
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
二氢杨梅素通过线粒体代谢重编程抑制DNA同源重组修复逆转口腔癌细胞放疗抵抗的机制研究
-
批准号:2026JJ80500
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:阳帆
-
依托单位:
乳酸通过ESM1-Akt-MDM2-p53通路调控卵巢癌DNA损伤和抗肿瘤免疫应答的分子机制研究
-
批准号:2026JJ81975
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:肖娇
-
依托单位:
淫羊藿苷通过TET2介导DNA去甲基化调控Hippo-YAP/TAZ通路逆转绝经后骨质疏松症成血管-成骨耦联失衡的机制研究
-
批准号:2026JJ82371
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:王哲享
-
依托单位:
CDC45通过调控DNA复制应激促进肝癌发生发展的机制
-
批准号:2026JJ82714
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:赵志坚
-
依托单位:
基于孕妇外周血游离DNA靶向捕获测序筛查胎儿隐性单基因病的探索研究
-
批准号:JCZRLH202600067
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
WSTF/SNF2H 介导的 DNA 损伤在 DPSCs 衰老中的机制研究
-
批准号:ZCLQN26H1401
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:虞其豪
-
依托单位:
孕期多环芳烃暴露与DNA甲基化改变对子代神经发育影响的出生队列研究
-
批准号:2026JJ81844
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:吕玲双
-
依托单位: